V

VistaGen Therapeutics
D

VTGN

2.37000
USD
-0.01
(-0.42%)
مغلق
حجم التداول
2,482
الربح لكل سهم
-2
العائد الربحي
-
P/E
-2
حجم السوق
68,403,141
أصول ذات صلة
ABBV
ABBV
5.160
(2.67%)
198.440 USD
A
APVO
-0.02420
(-4.85%)
0.47490 USD
C
CLDX
-0.020
(-0.10%)
20.660 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
M
MNKD
0.05500
(1.11%)
4.99500 USD
MRK
MRK
-0.090
(-0.11%)
83.160 USD
S
SUPN
0.380
(1.17%)
32.840 USD
T
TBPH
-0.015
(-0.14%)
10.370 USD
المزيد
الأخبار المقالات

العنوان: VistaGen Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.